Literature DB >> 24890320

Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer.

Hiroshi Ueda1, Shohei Aikawa2, Yousuke Kashima3, Junko Kikuchi3, Yasuo Ida3, Tadatsugu Tanino2, Kazunori Kadota4, Yuichi Tozuka4.   

Abstract

The mechanism of how poly(vinyl alcohol-co-acrylic acid-co-methyl methacrylate) (PVA copolymer) stabilizes an amorphous drug was investigated. Solid dispersions of PVA copolymer, poly(vinyl pyrrolidone) (PVP), and poly(vinyl pyrrolidone-co-vinyl acetate) (PVPVA) with indomethacin (IMC) were prepared. The glass transition temperature (Tg)-proportion profiles were evaluated by differential scanning calorimetry (DSC). General Tg profiles decreasing with the IMC ratio were observed for IMC-PVP and IMC-PVPVA samples. An interesting antiplasticizing effect of IMC on PVA copolymer was observed; Tg increased up to 20% IMC ratio. Further addition of IMC caused moderate reduction with positive deviation from theoretical values. Specific hydrophilic and hydrophobic interactions between IMC and PVA copolymer were revealed by infrared spectra. The indole amide of IMC played an important role in hydrogen bonding with PVA copolymer, but not with PVP and PVPVA. X-ray diffraction findings and the endotherm on DSC profiles suggested that PVA copolymer could form a semicrystalline structure and a possibility of correlation of the crystallographic nature with its low hygroscopicity was suggested. PVA copolymer was able to prevent crystallization of amorphous IMC through both low hygroscopicity and the formation of a specific intermolecular interaction compared with that with PVP and PVPVA.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  FT-IR; PVA copolymer; amorphous; crystallization; glass transition; intermolecular interaction; solid dispersion; stabilization

Mesh:

Substances:

Year:  2014        PMID: 24890320     DOI: 10.1002/jps.24023

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Authors:  Xia Lin; Yang Hu; Lei Liu; Lili Su; Na Li; Jing Yu; Bo Tang; Ziyi Yang
Journal:  Pharm Res       Date:  2018-04-23       Impact factor: 4.200

2.  Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions.

Authors:  Joseph W Lubach; Jonathan Hau
Journal:  Pharm Res       Date:  2018-02-20       Impact factor: 4.200

3.  A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs.

Authors:  Hiroshi Ueda; Noriyuki Muranushi; Satoshi Sakuma; Yasuo Ida; Takeshi Endoh; Kazunori Kadota; Yuichi Tozuka
Journal:  Pharm Res       Date:  2015-12-24       Impact factor: 4.200

4.  A Multivariate Approach for the Determination of the Optimal Mixing Ratio of the Non-Strong Interacting Co-Amorphous System Carvedilol-Tryptophan.

Authors:  Rong Di; Jingwen Liu; Holger Grohganz; Thomas Rades
Journal:  Molecules       Date:  2021-02-04       Impact factor: 4.411

5.  Stability and Influence of Storage Conditions on Nanofibrous Film Containing Tooth Whitening Agent.

Authors:  Siriporn Okonogi; Adchareeya Kaewpinta; Pisaisit Chaijareenont
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

6.  Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation.

Authors:  Kimberly B Shepard; David T Vodak; Philip J Kuehl; David Revelli; Yue Zhou; Amanda M Pluntze; Molly S Adam; Julia C Oddo; Lauren Switala; Jonathan L Cape; John M Baumann; Michael Banks
Journal:  AAPS PharmSciTech       Date:  2021-08-31       Impact factor: 3.246

7.  Applicability of an Experimental Grade of Hydroxypropyl Methylcellulose Acetate Succinate as a Carrier for Formation of Solid Dispersion with Indomethacin.

Authors:  Hiroshi Ueda; Yuya Hirakawa; Hironori Tanaka; Tetsuya Miyano; Katsuji Sugita
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.